List of Imaging Companies in Australia - 4

Cyclomedica is a global leader in nuclear medicine and molecular imaging, focusing on innovative diagnostic solutions for respiratory diseases. As a subsidiary of Cyclopharm Limited, the company is known for its flagship product, Technegas®, a lung imaging agent that enables high-resolution ventilation scans for conditions such as pulmonary embolism and COPD. Founded on advancements in radiopharmaceutical technology, Cyclomedica aims to improve patient outcomes through early intervention and enhanced care protocols. The company has a strong global presence, having expanded into various markets since its inception. It offers additional products like Pertechnegas, a specialized diagnostic application, and Galligas, a PET imaging variant. Cyclomedica also employs 3D SPECT imaging to enhance diagnostic accuracy in nuclear pulmonology. With ongoing research initiatives and a strategic focus on U.S. market expansion, Cyclomedica continues to advance its mission of elevating standards in respiratory disease management.

Ferronova is an innovative medical device company, which has brought together a patented magnetic probe from the University of South Australia and iron magnetic nanoparticle technology from Victoria University of Wellington, to produce an advanced diagnostic system to improve the detection of cancer metastases. Ferronova has research collaborations with UniSA Future Industries Institute, the University of Sydney, and the University of New South Wales. Founded in 2016, Ferronova is backed by Uniseed, Artesian Ventures, ASX-listed investment group Powerhouse Ventures, PAN Ventures, UniSA Ventures and Wellington UniVentures. The South Australian government and Australian government have provided grant funding to develop the technology.

OncoRes Medical is developing an intraoperative imaging tool that translates the surgeon's sense of touch into a microscale image - improving surgical accuracy and reducing complication rates. Founded in 2016, OncoRes is a medical device company funded by the Medical Research Commercialisation Fund, developing patent-protected technology in collaboration with leading researchers at the University of Western Australia, the Harry Perkins Institute of Medical Research and breast cancer surgeons from the Western Australian Department of Health. For more information, visit our website www.oncoresmedical.com or contact us at info@oncoresmedical.com.

Optiscan Imaging Ltd (ASX: OIL) is a global leader in the development, manufacture and commercialisation of endomicroscopic digital imaging technology solutions for medical, translational and pre-clinical applications. Our unique technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. We are driven by delivering digital healthcare solutions giving healthcare providers and researchers high quality, live, microscopic images and associated tools. Our technology helps facilitate earlier detection and management of disease thus improving patient outcomes and reducing the cost of curative medicine and associated procedures within healthcare systems. We are united in the common pursuit of revolutionising healthcare with live digital microscopic solutions that enable immediate informed decisions, provide economic efficiencies within health systems and improve patient outcomes.